Trial intelligence / Profile preview

Nalbuphine for Emergence Agitation in Ruptured Globe Repair

NCT03470077Phase 2Completed

Sponsor
Assiut University
Start
Jul 2019
Primary completion
Sep 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of nalbuphine in Emergence agitation (EA), sponsored by Assiut University. Started Jul 2019; status: completed.

02

Drugs

nalbuphine
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT03470077.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03470077.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call